ArticlePloS one2014
Toward an optimal global stem cell donor recruitment strategy.
Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Age-dependent HLA profiles of the Israeli population: impact on hematopoietic cell donor recruitment and availability.Immunogenetics · 2014Trial
- HLA allele and haplotype frequencies of eight Indian populations based on 130,518 registered stem cell donors.Frontiers in immunology · 2025Article
- Optimisation of global stem cell donor recruitment based on analysis of unsuccessful donor searches.HLA · 2024Article
- 5 years DKMS Chile: approach, results and impact of the first unrelated stem cell donor center in Chile.Frontiers in medicine · 2023Article
- HLA allele and haplotype frequencies of registered stem cell donors in Chile.Frontiers in immunology · 2023Article
- Should results of HLA haplotype frequency estimations be normalized?International journal of immunogenetics · 2021Article
- Estimating HLA haplotype frequencies from homozygous individuals - A Technical Report.International journal of immunogenetics · 2021Article
- Revisit of Optimal Donor Number Estimation in the Hong Kong Bone Marrow Donor Registry.Frontiers in immunology · 2021Article
- Immunogenetics in stem cell donor registry work: The DKMS example (Part 1).International journal of immunogenetics · 2020Review
- Estimation of German KIR Allele Group Haplotype Frequencies.Frontiers in immunology · 2020Article
- How Ancestry Influences the Chances of Finding Unrelated Donors: An Investigation in Admixed Brazilians.Frontiers in immunology · 2020Article
- Availability of HLA-allele-matched unrelated donors: estimation from haplotype frequency in the Japanese population.Bone marrow transplantation · 2019Article
- Hapl-o-Mat: open-source software for HLA haplotype frequency estimation from ambiguous and heterogeneous data.BMC bioinformatics · 2017Article
- Article
- Simulation shows that HLA-matched stem cell donors can remain unidentified in donor searches.Scientific reports · 2016Article
- Article
- Banking or Bankrupting: Strategies for Sustaining the Economic Future of Public Cord Blood Banks.PloS one · 2015Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Population-specific matching probabilities (MP) are a key parameter to assess the benefits of unrelated stem cell donor registries and the need for further donor recruitment efforts. In this study, we describe a general framework for MP estimations of specific and mixed patient populations under consideration of international stem cell donor exchange. Calculations were based on population-specific 4-locus (HLA-A, -B, -C, -DRB1) high-resolution haplotype frequencies (HF) of up to 21 populations. In various scenarios, we calculated several quantities of high practical relevance, including the maximal MP that can be reached by recruiting a fixed number of donors, the corresponding optimal composition by population of new registrants, and the minimal number of donors who need to be recruited to reach a defined MP. Starting at current donor numbers, the largest MP increases due to n = 500,000 additional same-population donors were observed for patients from Bosnia-Herzegovina (+0.25), Greece (+0.21) and Romania (+0.20). Especially small MP increases occurred for European Americans (+0.004), Germans (+0.01) and Hispanic Americans (+0.01). Due to the large Chinese population, the optimal distribution of n = 5,000,000 new donors worldwide included 3.9 million Chinese donors. As a general result of our calculations, we observed a need for same-population donor recruitment in order to increase population-specific MP efficiently. This result was robust despite limitations of our input data, including the use of HF derived from relatively small samples ranging from n = 1028 (Bosnia-Herzegovina) to n = 33,083 (Turkey) individuals. National strategies that neglect domestic donor recruitment should therefore be critically re-assessed, especially if only few donors have been recruited so far.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.